Orser Capital Management’s Merck MRK Stock Holding History

Orser Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,729	Closed	-$214K	–	41
2024 Q2	$214K	Sell	1,729 -70	-4%	-$9.02K	0.16%	41
2024 Q1	$237K	Sell	1,799 -210	-10%	-$25.9K	0.22%	42
2023 Q4	$219K	Sell	2,009 -7,145	-78%	-$742K	0.24%	42
2023 Q3	$942K	Sell	9,154 -120	-1%	-$12.9K	0.93%	37
2023 Q2	$1.07M	Sell	9,274 -35	-0.4%	-$3.97K	1.07%	34
2023 Q1	$990K	Buy	+9,309	New	+$1.01M	1.12%	33
2021 Q1	–	Sell	-13,291	Closed	-$1.04M	–	93
2020 Q4	$1.04M	Buy	13,291 +6,419	+93%	+$491K	0.66%	48
2020 Q3	$544K	Hold	6,872	–	–	0.43%	52
2020 Q2	$507K	Hold	6,872	–	–	0.46%	44
2020 Q1	$504K	Buy	+6,872	New	+$540K	0.71%	35
2018 Q1	–	Sell	-6,708	Closed	-$404K	–	106
2017 Q4	$404K	Buy	+6,708	New	+$372K	0.36%	82

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Orser Capital Management's MRK Position: Q3 2024 in Review

Orser Capital Management sold out of Merck (MRK) in Q3 2024, closing a stake of 1,729 shares — an estimated $214K sold.

Orser Capital Management first reported a position in MRK in Q4 2017 and held it in 11 quarters. The position peaked at $1.07M in Q2 2023. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

Orser Capital Management reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
Orser Capital Management sold 1,729 Merck shares in Q3 2024, an estimated $214K.
Orser Capital Management first reported a position in Merck in Q4 2017 and held it in 11 quarters.
Orser Capital Management's Merck position peaked at $1.07M in Q2 2023.
3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Orser Capital Management's 13F filing for Q3 2024, filed 4 Oct 2024.